Eli Lilly is moving to deepen its bet on inflammatory disease, striking a deal to acquire biotech player Ventyx Biosciences ...

The Oracle of Omaha has long favored concentrating capital in his best ideas, which is a belief that will continue under ...

Over the past decade, comedian Ron Funches has built an impressive acting résumé. With appearances on Black-ish, New Girl, ...

Organizations have a wealth of unstructured data that most AI models can’t yet read. Preparing and contextualizing this data ...

The topic of AI and its implications for orthopedic surgeons became of high personal importance when Bill Gates predicted that AI would replace physicians and others within the next decade. As an ...

New C-suite job titles can be confusing. Here's a breakdown of traditional and modern C-suite roles and why job titles must ...

DuckDB has recently introduced end-to-end interaction with Iceberg REST Catalogs directly within a browser tab, requiring no ...

Pensacola's 2025 began with a snowstorm and ended with the city taking on its largest project since Community Maritime Park.

Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

One of the biggest challenges in rolling out AI across enterprise environments is fully tapping into each organization's unique requirements, data sets, and existing infrastructure. If you're a ...